{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["glucose 6 phosphatase", "hepatic glucose output", "medicinal plant", "traditional medicine", "type 2 diabetes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32194426", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "03", "Day": "03"}], "Language": ["eng"], "ELocationID": ["215", "10.3389/fphar.2020.00215"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Hepatic Glucose Output Inhibition by Mexican Plants Used in the Treatment of Type 2 Diabetes.", "Pagination": {"StartPage": "215", "MedlinePgn": "215"}, "Abstract": {"AbstractText": ["<i>De novo</i> hepatic glucose production or hepatic gluconeogenesis is the main contributor to hyperglycemia in the fasting state in patients with type 2 diabetes (T2D) owing to insulin resistance, which leads to at least twice as much glucose synthesis compared to healthy subjects. Therefore, control of this pathway is a promising target to avoid the chronic complications associated with elevated glucose levels. Patients with T2D in the rural communities of Mexico use medicinal plants prepared as infusions that are consumed over the day between meals, thus following this rationale (consumption of the infusions in the fasting state), one approach to understanding the possible mechanism of action of medicinal plants is to assess their capacity to inhibit hepatic glucose production. Furthermore, in several of these plants, the presence of phenolic acids able to block the enzyme glucose-6-phosphatase (G6Pase) is reported. In the present work, extracts of <i>Ageratina petiolaris</i>, <i>Bromelia karatas</i>, <i>Equisetum myriochaetum</i>, <i>Rhizophora mangle</i>, and <i>Smilax moranensis</i>, which are Mexican plants that have been traditionally used to treat T2D, were assayed to evaluate their possible hepatic glucose output (HGO) inhibitory activity with a pyruvate tolerance test in 18-h fasted STZ-NA Wistar rats after oral administration of the extracts. In addition, the <i>in vitro</i> effects of the extracts on the last HGO rate-limiting enzyme G6Pase was analyzed. Our results showed that four of these plants had an effect on hepatic glucose production in the <i>in vivo</i> or <i>in vitro</i> assays. <i>A. petiolaris</i> and <i>R. mangle</i> extracts decreased glucose output, preventing an increase in the blood glucose levels and sustaining this prevented increase after pyruvate administration. Moreover, both extracts inhibited the catalytic activity of the G6Pase complex. On the other hand, even though <i>S. moranensis</i> and <i>B. karatas</i> did not exhibit a significant <i>in vivo</i> effect, <i>S. moranensis</i> had the most potent inhibitory effect on this enzymatic system, while the <i>E. myriochaetum</i> extract only inhibited hepatic glucose production in the pyruvate tolerance test. Because of the traditional method in which diabetic patients use plants, hepatic glucose production inhibition seems to be a mechanism that partially explains the common hypoglycemic effect. However, further studies must be carried out to characterize other mechanisms whereby these plants can decrease HGO."], "CopyrightInformation": "Copyright \u00a9 2020 Mata-Torres, Andrade-Cetto, Espinoza-Hern\u00e1ndez and C\u00e1rdenas-V\u00e1zquez."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Etnofarmacolog\u00eda, Facultad de Ciencias, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City, Mexico."}], "LastName": "Mata-Torres", "ForeName": "Gerardo", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Etnofarmacolog\u00eda, Facultad de Ciencias, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City, Mexico."}], "LastName": "Andrade-Cetto", "ForeName": "Adolfo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Etnofarmacolog\u00eda, Facultad de Ciencias, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City, Mexico."}], "LastName": "Espinoza-Hern\u00e1ndez", "ForeName": "Fernanda Artemisa", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Biolog\u00eda Animal Experimental, Facultad de Ciencias, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City, Mexico."}], "LastName": "C\u00e1rdenas-V\u00e1zquez", "ForeName": "Ren\u00e9", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Agius L. (2007). New hepatic targets for glycaemic control in diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 21 587\u2013605. 10.1016/j.beem.2007.09.001", "ArticleIdList": ["10.1016/j.beem.2007.09.001", "18054737"]}, {"Citation": "Alkhalidy H., Moore W., Wang A., Luo J., McMillan R. P., Wang Y., et al. (2018). Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice. J. Nutr. Biochem. 58 90\u2013101. 10.1016/j.jnutbio.2018.04.014", "ArticleIdList": ["10.1016/j.jnutbio.2018.04.014", "PMC6095729", "29886193"]}, {"Citation": "\u00c1lvarez-Cilleros D., Mart\u00edn M. \u00c1., Ramos S. (2018). (-)-Epicatechin and the colonic 2,3-dihydroxybenzoic acid metabolite regulate glucose uptake, glucose production, and improve insulin signaling in renal NRK-52E cells. Mol. Nutr. Food Res. 62 1\u20139. 10.1002/mnfr.201700470", "ArticleIdList": ["10.1002/mnfr.201700470", "29205863"]}, {"Citation": "Andrade-Cetto A. (2011a). Hypoglycemic effect of Smilax moranensis root on N5-STZ diabetic rats. Pharmacol. OnLine 1 111\u2013115."}, {"Citation": "Andrade-Cetto A. (2011b). Inhibition of gluconeogenesis by Malmea depressa root. J. Ethnopharmacol. 137 930\u2013933. 10.1016/j.jep.2011.06.028", "ArticleIdList": ["10.1016/j.jep.2011.06.028", "21756989"]}, {"Citation": "Andrade-Cetto A. (2012). Effects of medicinal plant extracts on gluconeogenesis. Bot. Targets Ther. 2 1\u20136. 10.2147/BTAT.S24726", "ArticleIdList": ["10.2147/BTAT.S24726"]}, {"Citation": "Andrade-Cetto A., Becerra-Jim\u00e9nez J., C\u00e1rdenas-V\u00e1zquez R. (2008). Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes. J. Ethnopharmacol. 116 27\u201332. 10.1016/j.jep.2007.10.031", "ArticleIdList": ["10.1016/j.jep.2007.10.031", "18082348"]}, {"Citation": "Andrade-Cetto A., Cabello-Hern\u00e1ndez C. A., C\u00e1rdenas-V\u00e1zquez R. (2015). Alpha-glucosidase inhibiting activity of five mexican plants used in the treatment of type 2 diabetes. Pharmacol. OnLine 1 67\u201371.", "ArticleIdList": ["18082348"]}, {"Citation": "Andrade-Cetto A., C\u00e1rdenas-V\u00e1zquez R. (2010). Gluconeogenesis inhibition and phytochemical composition of two Cecropia species. J. Ethnopharmacol. 130 93\u201397. 10.1016/j.jep.2010.04.016", "ArticleIdList": ["10.1016/j.jep.2010.04.016", "20420891"]}, {"Citation": "Andrade-Cetto A., Escand\u00f3n-Rivera S. M., Mata Torres-Valle G., Quijano L. (2017). Phytochemical composition and chronic hypoglycemic effect of Rhizophora mangle cortex on STZ-NA-induced diabetic rats. Rev. Bras. Farmacogn. 27 744\u2013750. 10.1016/j.bjp.2017.09.007", "ArticleIdList": ["10.1016/j.bjp.2017.09.007"]}, {"Citation": "Andrade-Cetto A., Heinrich M. (2005). Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J. Ethnopharmacol. 99 325\u2013348. 10.1016/j.jep.2005.04.019", "ArticleIdList": ["10.1016/j.jep.2005.04.019", "15964161"]}, {"Citation": "Andrade-Cetto A., Medina-Hern\u00e1ndez A. E. (2013). Hypoglycemic effect of Bromelia plumieri (E. Morren) L.B. Sm., leaves in STZ-NA-induced diabetic rats. Front. Pharmacol. 4:36. 10.3389/fphar.2013.00036", "ArticleIdList": ["10.3389/fphar.2013.00036", "PMC3620562", "23576986"]}, {"Citation": "Andrade-Cetto A., Rubalcaba-Mares M. L. (2012). Hypoglycemic effect of the Rhizophora mangle cortex on STZ-NA- induced diabetic rats. Pharmacol. OnLine 3 1\u20135."}, {"Citation": "Andrade-Cetto A., Wiedenfeld H., Revilla M. C., Islas S. (2000). Hypoglycemic effect of Equisetum myriochaetum aerial parts on streptozotocin diabetic rats. J. Ethnopharmacol. 72 129\u2013133. 10.1016/s0378-8741(00)00218-x", "ArticleIdList": ["10.1016/s0378-8741(00)00218-x", "10967463"]}, {"Citation": "Arion W. J. (1989). \u201cMeasurement of intactness of rat liver endoplasmic reticulum,\u201d in Methods in Enzymology, eds Fleischer S., Fleischer B., Abelson J., Simon M. (Cambridge, MA: Academic Press; ), 58\u201367. 10.1016/0076-6879(89)74010-6", "ArticleIdList": ["10.1016/0076-6879(89)74010-6", "2561171"]}, {"Citation": "Bailey C. J. (2017). Metformin: historical overview. Diabetologia 60 1566\u20131576. 10.1007/s00125-017-4318-z", "ArticleIdList": ["10.1007/s00125-017-4318-z", "28776081"]}, {"Citation": "Bustos-Brito C., Andrade-Cetto A., Giraldo-Aguirre J. D., Moreno-Vargas A. D., Quijano L. (2016). Acute hypoglycemic effect and phytochemical composition of Ageratina petiolaris. J. Ethnopharmacol. 185 341\u2013346. 10.1016/j.jep.2016.03.048", "ArticleIdList": ["10.1016/j.jep.2016.03.048", "27013093"]}, {"Citation": "Cersosimo E., Triplitt C., Solis-Herrera C., Mandarino L. J., DeFronzo R. A. (2018). Pathogenesis of Type 2 Diabetes Mellitus. South Dartmouth, MA: MDText.com, Inc."}, {"Citation": "Charkoudian L. K., Farrell B. P., Khosla C. (2012). Natural product inhibitors of glucose-6-phosphate translocase. Medchemcomm 3:926 10.1039/c2md20008b", "ArticleIdList": ["10.1039/c2md20008b"]}, {"Citation": "Cordero-Herrera I., Mart\u00edn M. \u00c1, Goya L., Ramos S. (2014). Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells. Food Chem. Toxicol. 64 10\u201319. 10.1016/j.fct.2013.11.014", "ArticleIdList": ["10.1016/j.fct.2013.11.014", "24262486"]}, {"Citation": "Eddouks M., Chattopadhyay D., Zeggwagh N. A. (2012). Animal models as tools to investigate antidiabetic and anti-inflammatory plants. Evid. Based. Complement. Alternat. Med. 2012:142087. 10.1155/2012/142087", "ArticleIdList": ["10.1155/2012/142087", "PMC3414199", "22899950"]}, {"Citation": "Escand\u00f3n-Rivera S. M., Andrade-Cetto A., S\u00e1nchez-Villase\u00f1or G. (2019). Phytochemical composition and chronic hypoglycemic effect of Bromelia karatas on STZ-NA-induced diabetic rats. evidence-based complement. Altern. Med. 2019:9276953. 10.1155/2019/9276953", "ArticleIdList": ["10.1155/2019/9276953", "PMC6413380", "30930951"]}, {"Citation": "Foretz M., Guigas B., Bertrand L., Pollak M., Viollet B. (2014). Metformin: from mechanisms of action to therapies. Cell Metab. 20 1\u201314. 10.1016/j.cmet.2014.09.018", "ArticleIdList": ["10.1016/j.cmet.2014.09.018", "25456737"]}, {"Citation": "Gao Y., Zhang M., Wang T., Wu T., Ai R., Zhang Z. (2016). Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K/Akt signaling pathway. Mol. Cell. Endocrinol. 433 26\u201334. 10.1016/j.mce.2016.05.013", "ArticleIdList": ["10.1016/j.mce.2016.05.013", "27212205"]}, {"Citation": "Hardie D. G. (2013). Metformin-acting through cyclic AMP as well as AMP? Cell Metab. 17 313\u2013314. 10.1016/j.cmet.2013.02.011", "ArticleIdList": ["10.1016/j.cmet.2013.02.011", "23473026"]}, {"Citation": "Hemmerle H., Burger H. J., Below P., Schubert G., Rippel R., Schindler P. W., et al. (1997). Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem. 40 137\u2013145. 10.1021/jm9607360", "ArticleIdList": ["10.1021/jm9607360", "9003513"]}, {"Citation": "Hunter R. W., Hughey C. C., Lantier L., Sundelin E. I., Peggie M., Zeqiraj E., et al. (2018). Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nat. Med. 24 1395\u20131406. 10.1038/s41591-018-0159-7", "ArticleIdList": ["10.1038/s41591-018-0159-7", "PMC6207338", "30150719"]}, {"Citation": "International Diabetes Federation (2017). IDF Diabetes Atlas, 8th Edn Brussels: International Diabetes Federation."}, {"Citation": "Jawad A. H., Ibrahim A. E., Alsayed R., Hallab Z. S., Al-qaisi Z. (2016). Study the impact of glucose-6-phosphatase activity in type 2 diabetic patients and non diabetic counterparts. Preprints 2016100137 1\u20136. 10.20944/preprints201610.0137.v1", "ArticleIdList": ["10.20944/preprints201610.0137.v1"]}, {"Citation": "Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-buys D., et al. (1998). Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes Metab. Res. Rev 47 224\u2013229. 10.2337/diab.47.2.224", "ArticleIdList": ["10.2337/diab.47.2.224", "9519717"]}, {"Citation": "Meng S., Cao J., Feng Q., Peng J., Hu Y. (2013). Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evidence-Based Complement. Altern. Med. 2013 1\u201311. 10.1155/2013/801457", "ArticleIdList": ["10.1155/2013/801457", "PMC3766985", "24062792"]}, {"Citation": "National Research Council (2011). Guide for the Care and Use of Laboratory Animals, 8th Edn Washington, DC: National Academies Press."}, {"Citation": "Naveed M., Hejazi V., Abbas M., Kamboh A. A., Khan G. J., Shumzaid M., et al. (2018). Chlorogenic acid (CGA): a pharmacological review and call for further research. Biomed. Pharmacother. 97 67\u201374. 10.1016/j.biopha.2017.10.064", "ArticleIdList": ["10.1016/j.biopha.2017.10.064", "29080460"]}, {"Citation": "Ong K. W., Hsu A., Tan B. K. H. (2013). Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by AMPK activation. Biochem. Pharmacol. 85 1341\u20131351. 10.1016/j.bcp.2013.02.008", "ArticleIdList": ["10.1016/j.bcp.2013.02.008", "23416115"]}, {"Citation": "Revilla M. C. C., Andrade-Cetto A., Islas S., Wiedenfeld H. (2002). Hypoglycemic effect of Equisetum myriochaetum aerial parts on type 2 diabetic patients. J. Ethnopharmacol. 81 117\u2013120. 10.1016/S0378-8741(02)00053-3", "ArticleIdList": ["10.1016/S0378-8741(02)00053-3", "12020935"]}, {"Citation": "Romo-P\u00e9rez A., Escand\u00f3n-Rivera S. M., Andrade-Cetto A. (2019). Chronic hypoglycemic effect and phytochemical composition of Smilax moranensis roots. Brazilian J. Pharmacogn. 29 246\u2013253. 10.1016/j.bjp.2019.02.007", "ArticleIdList": ["10.1016/j.bjp.2019.02.007"]}, {"Citation": "Sharabi K., Tavares C., Rines A., Puigserver P. (2015). Molecular pathophysiology of hepatic glucose production. Mol. Aspects Med. 46 21\u201333. 10.1016/j.mam.2015.09.003", "ArticleIdList": ["10.1016/j.mam.2015.09.003", "PMC4674831", "26549348"]}, {"Citation": "Szkudelski T. (2012). Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med. 237 481\u2013490. 10.1258/ebm.2012.011372", "ArticleIdList": ["10.1258/ebm.2012.011372", "22619373"]}, {"Citation": "Szkudelski T., Szkudelska K. (2015). Resveratrol and diabetes: from animal to human studies. Biochim. Biophys. Acta Mol. Basis Dis. 1852 1145\u20131154. 10.1016/j.bbadis.2014.10.013", "ArticleIdList": ["10.1016/j.bbadis.2014.10.013", "25445538"]}, {"Citation": "Szkudelski T., Zywert A., Szkudelska K. (2013). Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes. Physiol. Res. 62 663\u2013670.", "ArticleIdList": ["23869889"]}, {"Citation": "Tan M. H., Alquraini H., Mizokami-Stout K., MacEachern M. (2016). Metformin: from research to clinical practice. Endocrinol. Metab. Clin. North Am. 45 819\u2013843. 10.1016/j.ecl.2016.06.008", "ArticleIdList": ["10.1016/j.ecl.2016.06.008", "27823607"]}, {"Citation": "van Schaftingen E., Gerin I. (2002). The glucose-6-phosphatase system. Biochem. J. 362, 513\u201332. 10.1042/0264-6021:3620513.", "ArticleIdList": ["10.1042/0264-6021:3620513", "PMC1222414", "11879177"]}, {"Citation": "Viollet B., Foretz M. (2013). Revisiting the mechanisms of metformin action in the liver. Ann. Endocrinol. 74 123\u2013129. 10.1016/j.ando.2013.03.006", "ArticleIdList": ["10.1016/j.ando.2013.03.006", "23582849"]}, {"Citation": "Wiedenfeld H., Andrade Cetto A., Perez Amador C. (2000). Flavonol glycosides from Equisetum myriochaetum. Biochem. Syst. Ecol. 28 395\u2013397. 10.1016/S0305-1978(99)00074-5", "ArticleIdList": ["10.1016/S0305-1978(99)00074-5", "10725596"]}, {"Citation": "Ziberna L., Fornasaro S., \u010cvorovi\u0107 J., Tramer F., Passamonti S. (2014). \u201cBioavailability of flavonoids: the role of cell membrane transporters,\u201d in Polyphenols in Human Health and Disease, eds Watson R. R, Preedy V. R., Zibadi S. (Cambridge, MA: Academic Press; ), 489\u2013511."}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "8", "Day": "29"}, {"Year": "2020", "Month": "2", "Day": "14"}, {"Year": "2020", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "3", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["32194426", "PMC7065531", "10.3389/fphar.2020.00215"]}}], "PubmedBookArticle": []}